COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: ANIF1 with specific doses of 10 cc as an oral syrup, 2 times a day for 7 days. Intervention 2: Control group: standard medication regimen according to the national
Sponsors
Mazandaran University of Medical Sceinces
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: COVID-19 diagnosis based on Lung Ct-Scan COVID-19 diagnosis based on RT-PCR Lymphopenia less than 1100 fever more than 38 degrees Positive CRP Positive respiratory symptoms Gastroitestinal symptms
Exclusion criteria
Exclusion criteria: intubated patients with severe respiratory disease patients with severe co-morbidity and end stage disease Oral intolerance onset of symptoms more than 10 days pregnant women severe Immuncompromised patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RT-PCR test.IL-6,CRP. Timepoint: at the beginning and end of study. Method of measurement: nasopharyngeal swab.;Lung CT-Scan. Timepoint: at the beginning and end of study. Method of measurement: CT-Scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory biomarkers IL6,CRP. Timepoint: at the beginning and end of study. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLotfollah Davoodi
Mazandaran University of Medical Sciences
Outcome results
None listed